Raymond James Financial’s MapLight Therapeutics MPLT Stock Holding History
Bought
Maintained
Sold
Other funds holding MPLT
Raymond James Financial's MPLT Position: Q3 2026 in Review
Raymond James Financial sold out of MapLight Therapeutics (MPLT) in Q3 2026, closing a stake of 6,455 shares — an estimated $231K sold.
Raymond James Financial first reported a position in MPLT in Q2 2026 and held it in 1 quarter. The position peaked at $231K in Q2 2026. 60 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.
- Raymond James Financial reported no remaining MapLight Therapeutics position as of Q3 2026 after selling out during the quarter.
- Raymond James Financial sold 6,455 MapLight Therapeutics shares in Q3 2026, an estimated $231K.
- Raymond James Financial first reported a position in MapLight Therapeutics in Q2 2026 and held it in 1 quarter.
- Raymond James Financial's MapLight Therapeutics position peaked at $231K in Q2 2026.
- 60 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.